SFRP5 and chronic kidney disease: Although the effect of sFRP5 in vascular disease is relatively unexplored, our study suggests that sFRP5 expression changes within calcified vascular tissues, so that not only changes in serum levels of sFRP5 in the CKD environment, but also paracrine effects in or around vascular tissues are affected.